CMS approves Medicaid waivers to treat substance use disorders
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.
Related News Articles
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Headline
The AHA commented Sept. 21 on the Centers for Medicare & Medicaid Services’ proposed rule to implement the changes to Medicaid provider tax policies that…
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
HHS awards $383 million in grants for suicide prevention, other behavioral health efforts on 988 Day
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…
Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
SAMHSA finds declines in use of alcohol, drugs in latest annual survey on drug use and mental health
The Substance Abuse and Mental Health Services Administration July 27 released results from its latest national survey on drug use and mental health. The…